The rise in multidrug-resistant bacteria highlights the critical need for novel antibiotics. This study explores clovibactin-like compounds as potential therapeutic agents targeting lipid II, a crucial component in bacterial cell wall synthesis, using in silico techniques. A total of 2624 clovibactin analogs were sourced from the PubChem database and screened using ProTox 3.0 software based on their ADME-Tox properties, prioritizing candidates with favorable pharmacokinetic profiles and minimal toxicity. Molecular docking protocols were then employed to assess the binding interactions of the selected compounds with lipid II. Our analysis identified Compound 22 as a particularly promising candidate, exhibiting strong binding affinity, stable complex formation, and high selectivity for the target. Binding energy analysis, conducted via molecular dynamics simulations, revealed a highly negative value of −25.50 kcal/mol for Compound 22, surpassing that of clovibactin and underscoring its potential efficacy. In addition, Compound 22 was prioritized due to its exceptional binding affinity to lipid II and its favorable ADME-Tox properties, suggesting a lower likelihood of adverse effects. These characteristics position Compound 22 as a promising candidate for further pharmacological development. While our computational results are encouraging, experimental validation is essential to confirm the efficacy and safety of these compounds. This study not only advances our understanding of clovibactin analogs but also contributes to the ongoing efforts to combat antimicrobial resistance through innovative antibiotic development.

Calotropis procera, a drought-tolerant shrub widely used in folk medicine, was evaluated for its antimicrobial potential and safety using an integrative in vitro/in silico workflow. Ethanolic leaf extract (EE-CP) displayed a dose-dependent inhibition of Staphylococcus aureus ATCC 2913 and Escherichia coli ATCC 35218, reaching 93% and 52% of the amoxicillin control, respectively (MIC 207 µg mL⁻¹ and 149 µg mL⁻¹). GC-MS and LC-HRMS profiling revealed cardenolides (strophanthidin, gitoxigenin) and indole derivatives as major constituents. Pharmacophore mapping highlighted the essential glycosyltransferase MurG as a likely bacterial target; molecular docking showed that strophanthidin and NCGC00384918 bind MurG more strongly than the native substrate UDP-GlcNAc (ΔG ≤ −9.4 kcal mol⁻¹), a result corroborated by 100 ns molecular dynamics simulations and MM-PBSA binding energies (−96.4 and −49.3 kcal mol⁻¹). EE-CP caused <10% hemolysis up to 1.5 mg mL⁻¹ and exhibited LC₅₀ values of 302 µg mL⁻¹ (human lymphocytes) and 247 µg mL⁻¹ (BHK-21 cells), indicating a narrow but exploitable therapeutic window. Collectively, these findings constitute the first report on Colombian C. procera demonstrating potent anti-Staphylococcus activity, MurG-targeted cardenolides, and acceptable erythrocyte compatibility. This study supports EE-CP as a promising source of lead molecules and antibiotic adjuvants, warranting guided fractionation and in vivo validation to optimize efficacy and mitigate cytotoxicity.

Hormone-dependent breast cancer, particularly in its treatment-resistant forms, remains a significant therapeutic challenge. In this study, we applied a fully computational strategy to design steroid-based compounds capable of simultaneously targeting three key receptors involved in disease progression: progesterone receptor (PR), estrogen receptor alpha (ER-α), and HER2. Using a robust 3D-QSAR model (R² = 0.86; Q²_LOO = 0.86) built from 52 steroidal structures, we identified molecular features associated with high anticancer potential, specifically increased polarizability and reduced electronegativity. From a virtual library of 271 DFT-optimized analogs, 31 compounds were selected based on predicted potency (pIC₅₀ > 7.0) and screened via molecular docking against PR (PDB 2W8Y), HER2 (PDB 7JXH), and ER-α (PDB 6VJD). Seven candidates showed strong binding affinities (ΔG ≤ −9 kcal/mol for at least two targets), with Estero-255 emerging as the most promising. This compound demonstrated excellent conformational stability, a robust hydrogen-bonding network, and consistent multitarget engagement. Molecular dynamics simulations over 100 nanoseconds confirmed the structural integrity of the top ligands, with low RMSD values, compact radii of gyration, and stable binding energy profiles. Key interactions included hydrophobic contacts, π–π stacking, halogen–π interactions, and classical hydrogen bonds with conserved residues across all three targets. These findings highlight Estero-255, alongside Estero-261 and Estero-264, as strong multitarget candidates for further development. By potentially disrupting the PI3K/AKT/mTOR signaling pathway, these compounds offer a promising strategy for overcoming resistance in hormone-driven breast cancer. Experimental validation, including cytotoxicity assays and ADME/Tox profiling, is recommended to confirm their therapeutic potential.

Fungal contamination during postharvest storage causes significant food losses, particularly due to Penicillium expansum and Penicillium brevicompactum, highlighting the need for sustainable antifungal alternatives. This study evaluated the antifungal potential of clove essential oil (Syzygium aromaticum) against P. expansum and P. brevicompactum by integrating in vitro assays with in silico analyses. Minimum inhibitory concentrations (MICs) were determined, and effects on fungal growth, membrane integrity, and spore germination were assessed. Molecular docking and molecular dynamics simulations were performed to evaluate the affinity and stability of the five most abundant GC–MS compounds that met predefined ProTox-II toxicity criteria (categories 5–6; LD₅₀ ≥ 2000 mg/kg) toward chitin synthase I (CHS I), a key enzyme in chitin biosynthesis. The oil exhibited strong inhibitory activity, with MIC values of 0.156 µL/mL against P. expansum and 0.312 µL/mL against P. brevicompactum, along with significant morphological and physiological alterations. Computational analyses indicated that trans-β-caryophyllene oxide and α-humulene form stable interactions at both the active and an allosteric site of CHS I, supporting a putative dual inhibitory mechanism. These findings highlight clove essential oil as a promising ecological alternative to synthetic fungicides and underscore the value of computational approaches for elucidating antifungal mechanisms in understudied species.

Oropouche virus (OROV), an emerging orthobunyavirus of increasing public health concern in the Americas, currently lacks approved antiviral therapies. In this study, we employed a structure-based in silico approach to identify natural antiviral scaffolds capable of targeting the Gc glycoprotein, a class II fusion protein essential for host membrane fusion and viral entry. A library of 537 plant-derived compounds was screened against the Gc head domain (PDB ID: 6H3X) through molecular docking and redocking, followed by 100-nanosecond molecular dynamics simulations, MM-PBSA free energy calculations, and ADMET profiling. Curcumin and Berberine emerged as standout candidates. Curcumin demonstrated a balanced profile, with stable binding (−38.14 kcal/mol), low backbone RMSD (1.82 Å), and consistent radius of gyration (Rg ~ 18.8 Å), suggesting strong conformational stability and compactness of the protein–ligand complex. Berberine exhibited the most favorable binding energy (−13.10 kcal/mol) and retained dynamic stability (RMSD 1.86 Å; Rg ~ 19.0 Å), though accompanied by predicted cytotoxicity that may require structural refinement. Both compounds induced reduced residue-level fluctuations (RMSF < 2.5 Å) in functionally critical regions of the Gc protein, consistent with a mechanism of action that involves stabilization of the prefusion conformation and interference with the structural transitions required for viral entry. These findings identify curcumin and berberine as promising scaffolds for anti-OROV drug development and offer a rational foundation for future experimental validation targeting viral fusion mechanisms.

Spider venoms are enriched in toxins that modulate mammalian voltage-gated ion channels (VGIC) with pharmacological potential. However, the inventory of toxins of American spiders with effects on voltage-gated Ca²⁺ channels has lagged the number of toxins interacting with other channels. Here, we aimed at identifying new Ca²⁺ channel-modulating toxins of the Colombian spider Pamphobeteus verdolaga. The sequences of five novel short, positively charged, disulfide-bridged peptides, and one more short, non-bridged control peptide, were selected from the transcriptomic database of the venom gland of P. verdolaga. Peptides were synthesized and screened at 1 μM for their effects on L-type Ca²⁺ currents (I_CaL) in mouse cardiomyocytes using patch-clamp. I_K were also evaluated to gain information about the selectivity of the peptides. 3D modeling, docking and molecular dynamics simulations were likewise performed. vrdg183 (19 amino acid residues, four cysteines, charge +7, 2.33 kDa), followed by vrdg69 and vrdg177, inhibited over 60 % of I_CaL. vrdg172 and vrdg164 showed a moderate effect of less than 40 %. vrdg183 had a half-maximal inhibitory concentration for I_CaL of 858.28 nM and was the only toxin lacking effect on I_K. vrdg183, consisting of two antiparallel β-strands, was successfully docked to the extracellular L6_IV loop at the outer pore region of the human cardiac Ca_v1.2 with a binding energy of -9.5 kJ/mol. This is the first report of toxins of P. verdolaga with effects on VGIC. vrdg183 highlights as a very low molecular weight, moderately potent I_CaL inhibitor through an allosteric mechanism, without effect on I_K.